4//SEC Filing
Peyer James 4
Accession 0000897069-25-001774
CIK 0001829802other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:36 PM ET
Size
11.2 KB
Accession
0000897069-25-001774
Insider Transaction Report
Form 4
Peyer James
Director10% Owner
Transactions
- Sale
Common Stock
2025-12-04$9.06/sh−5,000$45,300→ 177,654 total(indirect: See footnote) - Sale
Common Stock
2025-12-05$11.40/sh−14,508$165,391→ 163,146 total(indirect: See footnote) - Sale
Common Stock
2025-12-05$12.29/sh−1,745$21,446→ 161,401 total(indirect: See footnote) - Sale
Common Stock
2025-12-05$13.16/sh−42$553→ 161,359 total(indirect: See footnote)
Footnotes (6)
- [F1]The price reported in Column 4 is a weighted average price. The prices sold ranged from $9.00 to $9.54. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]The amount shown reflects the number of shares held following the reported transaction, as adjusted for a 1-for-20 stock split effectuated by the issuer.
- [F3]These shares are held by Cambrian Biopharma Inc, a Delaware corporation ("Cambrian"). The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.
- [F4]The price reported in Column 4 is a weighted average price. The prices sold ranged from $11.00 to $12.00. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The price reported in Column 4 is a weighted average price. The prices sold ranged from $12.02 to $12.95. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]The price reported in Column 4 is a weighted average price. The prices sold ranged from $13.00 to $13.26. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
Related Parties
1- filerCIK 0001843594
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 4:36 PM ET
- Size
- 11.2 KB